Priyanka Grover

Stock Analyst at JP Morgan

(n/a)

# 5,009

Out of 5,240 analysts

Total ratings

n/a

Success rate

-59.04%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Priyanka Grover

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	RXRX Recursion Pharmaceuticals	Maintains: Overweight	$11 → $10	$3.09	+223.62%	1	Apr 30, 2026
	MREO Mereo BioPharma Group	Downgrades: Neutral	n/a	$0.25	-	3	Mar 23, 2026

Recursion Pharmaceuticals

Apr 30, 2026

Maintains: Overweight

Price Target: $11 → $10

Current: $3.09

Upside: +223.62%

Mereo BioPharma Group

Mar 23, 2026

Downgrades: Neutral

Price Target: n/a

Current: $0.25

Upside: -